TCMD

Tactile Systems Technology, Inc. - Common Stock

Congress Trades

Actor	Trade Size	Last Transaction	Amount Range		Current Price
Tina SmithDemocrat $75k4.8k shares BuyNov 12, 2024 $50k-$100k $15.75 $25.07

News

globenewswire.comTactile Medical Launches Next-Generation AffloVest® Airway Clearance Therapyglobenewswire.comJun 2

globenewswire.comTactile Medical to Present at the William Blair 46th Annual Growth Stock Conferenceglobenewswire.comMay 20

zacks.comShould Value Investors Buy Tactile Systems Technology (TCMD) Stock?zacks.comMay 6

seekingalpha.comTactile Systems Technology, Inc. (TCMD) Q1 2026 Earnings Call Transcriptseekingalpha.comMay 4

zacks.comTactile Systems Technology (TCMD) Reports Q1 Loss, Tops Revenue Estimateszacks.comMay 4

Trade TCMD

About Tactile Systems Technology, Inc.

Tactile Systems Technology, Inc., a medical technology company, engages in the development and provision of medical devices for chronic diseases in the United States. The company offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema; Entre system, a portable pneumatic compression device that is used for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers; and AffloVest, a portable high frequency chest wall oscillation test for the treatment of retained pulmonary secretions such as bronchiectasis, cystic fibrosis, and various neuromuscular disorders. The company was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.

CEO: Sheri Louise Dodd
IPO Date: Jul 28, 2016

Market Data

Open: $25.08
High: $25.65
Low: $25.08
Volume: 200.6K
52W High: $37.77
52W Low: $9.42

Valuation

Market Cap: $573M
Enterprise Value: $513M

Financials

Free Cash Flow: $40M
Revenue: $330M
Net Income: $19M
Cash: $83M
Debt: $16M

Events

EarningsAug 3

EPS est. 0.14